Targeting KCTD1 as a Potential Novel Therapy Ameliorates Hepatocellular Carcinoma Progression via the HIF-1α/VEGF Pathway

Xinyu Zhu; Zhiwei Li; Li Chen; Limin Li; Mi Ouyang; Hao Zhou; Kai Xiao; Ling Lin; Paul Kim Ho Chu; Chang Zhou; Chengfeng Xun; Liu Yang; Wenhuan Huang; Xiaofeng Ding

doi:10.2139/ssrn.4047141

Related publications

Article2025

Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway

Xinyu Zhu, Zhiwei Li, Li Chen, Limin Li, Mi Ouyang, Hao Zhou, Kai Xiao, Ling Lin, Paul Kim Ho Chu, Chang Zhou, Chengfeng Xun, Liu Yang, Wenhuan Huang, Xiaofeng Ding

Preprint2021

KCTD1 Downregulation Suppresses Hepatocellular Carcinoma by Regulating Angiogenesis and Influencing the HIF-1α/VEGF Pathway

Xinyu Zhu, Zhiwei Li, Limin Li, Li Chen, Mi Ouyang, Hao Zhou, Kai Xiao, Lin Ling, Paul Kim Ho Chu, Chang Zhou, Chengfeng Xun, Liu Yang, Wenhuan Huang, Xiaofeng Ding

Article2010

Inhibition of PlGF as a potential therapy against hepatocellular carcinoma

Femke Heindryckx, Lara Crapé, G Cornelis, Peter Carmeliet, Isabelle Colle, Hans Van Vlierberghe

Article2014

Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism

Florent Morfoisse, Anna Kuchnio, Clément Frainay, Anne Gomez‐Brouchet, Marie‐Bernadette Delisle, Stefano Marzi, Anne‐Catherine Helfer, Fransky Hantelys, Françoise Pujol, Julie Guillermet‐Guibert, Corinne Bousquet, Mieke Dewerchin, Stéphane Pyronnet, Anne‐Catherine Prats, Peter Carmeliet, Barbara Garmy‐Susini

Article2017

A potential role of cancer testis antigens in hepatocellular carcinoma progression

Amanda J. Craig, Carlos Villacorta-Martín, Ismaïl Labgaa, Mehmet Eren Ahsen, Sebastiao N. Martins‐Filho, Delia D’Avola, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Ganesh Gunasekaran, Swan N. Thung, Josep M. Llovet, Myron Schwartz, Gustavo Stolovitzky, Bojan Losic, Augusto Villanueva